. Author manuscript; available in PMC: 2010 Oct 1.

Published in final edited form as: Bone Marrow Transplant. 2009 Aug 17;45(4):662–667. doi: 10.1038/bmt.2009.210

Table 2.

Results of univariate analyses for all patients

	Univariate analysis
	HR	95% CI	P
Antifungal prophylaxis			0.046
Fluconazole/Itraconazole	1
Voriconazole	0.20	0.04–0.97
Donor source			0.06
Related	1
Unrelated	0.14	0.02–1.09
Age			0.23
< 50	1	0.03–2.22
> 50	0.28
Disease risk			0.37
Low	1
Intermediate	0.69	0.30–1.56
High	0.47	0.09–2.43
Regimen			0.15
Cyclophosphamide or TBI based	1
Fludarabine-based reduced intensity	0.31	0.06–1.51
Hematopoietic cell source			0.06
Bone marrow	1
Peripheral blood	0.27	0.07–1.08

CI, confidence interval; HR, hazard ratio.